Sign up to FoodBev and unlock more insights from the international food and beverage industry. Subscribers have access to webinars, newsletters, publications and more...
Resilience, not restriction: How GLP-1 is reshaping nutrition priorities
Vitafoods Europe's Francesca Berry explores how the focus is turning toward food quality over quantity – with new approaches to gut health and carbs under the spotlight.
Maeva launches GLP-1-focused nutrition system for weight loss support
US direct-to-consumer metabolic wellness brand, Maeva, has launched a nutrition system designed to support individuals using GLP-1 weight-loss medications, as adoption of the drugs continues to rise.
GLP-1 drugs begin to reshape food demand, forcing F&B firms to rethink the basket
As appetite-suppressing GLP-1 medications gain traction, new research from Cornell University suggests measurable shifts in food purchasing are emerging.
Weight-loss drugs: What happens to the food industry when appetite disappears?
Tom Ellis, CEO and co-owner at Brand Genetics, explains how the latest surge of weight-loss drugs is disrupting consumption and what’s next for producers.